StreetAlpha.app
Home › Stocks › INO

Inovio Pharmaceuticals, Inc. (INO)

Healthcare
$1.76
▲ +2.92%
LAST CLOSE · NOV 20

INOVIO develops DNA medicines and CELLECTRA delivery devices for diseases linked to HPV, cancer and infectious diseases. It last closed at $1.76 on Nov 20, up 2.92% on the day. The next earnings report for INO is expected around Thu, Mar 11, 2027, after the close. For the quarter ended Sep 2026, INO reported EPS of -$0.50 on revenue of $298,901. Over its last 8 reports the stock moved an average of 10.7% the session after earnings.

AI Auto Pilots
Is INO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INO.

Key Stats

Last 12 months
Results
Revenue
$299K
+63.9% vs a year ago
Net income
−$71.1M
−23798.9% margin
EPS (diluted)
−$0.59
Free cash flow
−$74.4M
−24894.9% margin
Valuation
Market cap
$329.7M
187.3M shares
P/E
–
No P/E while losing money
Price to sales
1102.9
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$47.0M
At Sep 30
Shareholder equity
−$33.9M
Shares outstanding
187.3M
At Nov 10
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $1.8M$1.8MFY2021FY2022: $10.3M$10.3MFY2022FY2023: $832K$832KFY2023FY2024: $218K$218KFY2024FY2025: $65K$65KFY2025

From INO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Next report
Mar 11
Estimated date · After the close
Reported EPS
-$0.50
Quarter ended Sep 2026
Year ago EPS
-$0.87
Same quarter last year
Revenue
$298,901
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.60Dec '24Mar 2025: -$0.51Mar '25Jun 2025: -$0.61Jun '25Sep 2025: -$0.87Sep '25Dec 2025: $0.31Dec '25Mar 2026: -$0.28Mar '26Jun 2026: -$0.07Jun '26Sep 2026: -$0.50Sep '26Latest -$0.50
Revenue by quarter
Dec 2024: $116,994Dec '24Mar 2025: $65,343Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Dec 2025: $0Dec '25Mar 2026: $0Mar '26Jun 2026: $0Jun '26Sep 2026: $298,901Sep '26Latest $298,901
How INO moved after its last 8 reports
Average move the session after a report ±10.7%
Nov 5, 2026After the close−16.2%
Jul 29, 2026After the close−36.9%
May 13, 2026After the close+1.5%
Mar 12, 2026After the close−1.2%
Nov 10, 2025After the close−7.0%
Aug 12, 2025After the close+14.1%
May 13, 2025After the close−2.1%
Mar 18, 2025After the close−6.7%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on INOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on INO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on INO

Technical Analysis

INO · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 22% above its 20 day and 31% above its 50 day average. It is 28% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 63), near overbought. The nearest support is the Pivot at $1.72, and the nearest resistance the Pivot R1 at $1.82.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 12.2%/day
Key levels
$2.7252 week high+54.5%
$2.17Swing high (Nov 2)+23.3%
$1.82Pivot R1+3.4%
$1.76Last close
$1.72Pivot−2.3%
$1.66Pivot S1−5.7%
$1.3720 day average−22.2%
$1.26200 day average−28.4%
$1.22Swing low (Sep 1)−30.7%
$1.2150 day average−31.3%
$1.15100 day average−34.7%
$0.5652 week low−68.2%
Indicators
RSI (14)63.02Strong, overbought above 70Neutral
MACD0.15Above its signal lineBullish
Stochastic66.3Middle of its rangeNeutral
ADX (14)25.2Trending up
Williams %R-28.9Oversold below −80, overbought above −20Neutral
CCI (20)80.8Oversold below −100, overbought above 100Neutral
Rate of change+44.9%Change over 10 sessionsBullish
ATR (14)$0.21Typical daily range, 12.2% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for INO

What happened before

See how INO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow INO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How INO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for INOHow many large options trades hit INO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

INO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲59 buying vs 34 selling
  • ▲Held by funds +16.0 pts
  • ▲Funds holding +4
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding112108+3.7%
In funds' top 1000–
Held by funds33.6%17.6%+16.0 pts
New / increased23 / 3622 / 27+20.4%
Reduced / sold out14 / 2014 / 18+6.3%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See INO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INO is in one of them and how their past INO trades turned out.

INO in the AI portfolios
Loading…

INO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered INO in an article yet. Here's the latest on the wider market.

INO in the news

INO Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Nov 6
Who traded INO · since 2020
Latest 1 filing
$1K – $15KTraded Sep 8, 2020Filed Nov 6, 2020
PersonTypeAmountTradedFiledDelay
Christopher JacobsR · NYSell$1K – $15KSep 8, 2020Nov 6, 202059 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Inovio Pharmaceuticals

INOVIO is a biotechnology company based in Plymouth Meeting, Pennsylvania. It develops DNA medicines meant to help treat and prevent diseases linked to human papillomavirus (HPV), certain cancers and infectious diseases. Its lead candidate, INO-3107, is being studied for recurrent respiratory papillomatosis, a rare condition that causes tumors in the airway. The company also develops CELLECTRA devices that deliver these medicines into the body's cells. Its intended customers are patients and the healthcare providers who treat them.

Headquarters
Plymouth Meeting, PA
Founded
1983